
John A Zitelli MD
Dermatologic Surgery
Associate Clinical Professor of Dermatology, University Pittsburgh
Join to View Full Profile
5200 Centre AveSuite 303Pittsburgh, PA 15232
Phone+1 412-681-9480
Fax+1 412-681-5240
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Zitelli, MD is a board certified dermatologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is an Associate Clinical Professor of Dermatology at University Pittsburgh.
Education & Training
- UPMC Medical EducationResidency, Dermatology, 1977 - 1980
- UPMC Medical EducationInternship, Internal Medicine, 1976 - 1977
- University of Pittsburgh School of MedicineClass of 1976
Certifications & Licensure
- PA State Medical License 1977 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective coho...Kathryn T Shahwan, Trent D Walker, Andrea Tan, Emily Ruiz, Nina Ran
Journal of the American Academy of Dermatology. 2025-02-24 - 1 citationsMohs for Melanoma: A Review of MART-1 Frozen Section Interpretation.James J Contestable, Geoffrey F S Lim, Tyler Willenbrink, John A Zitelli, David G Brodland
Dermatologic Surgery. 2024-12-01 - Most cutaneous squamous cell carcinoma recurrences occur in the first 3 years after diagnosis: A multicenter retrospective cohort study.Emily E Granger, Nina A Ran, Morgan K Groover, Shlomo A Koyfman, Allison T Vidimos
Journal of the American Academy of Dermatology. 2024-11-01
Press Mentions
- May Is Skin Cancer Awareness MonthMay 1st, 2021
- Excision with 5-Mm Margins Evaluated in Small Melanoma in SituJuly 2nd, 2024
- Can Narrow Margins Suffice for Some Smaller Low-Risk Melanomas in Situ?July 8th, 2024